Bio-Techne Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Bio-Techne Corporation income statement - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec 2025Jun 2024Jun 2023Jun 2022Jun 2021
Revenue & Gross Profit
Revenue1.221.161.141.110.93
Cost of Revenue0.430.390.370.350.30
Gross Profit0.790.770.770.760.63
Operating Expenses
Research & Development0.100.100.090.090.07
Selling, General & Administrative0.420.430.400.340.31
Operating Expenses0.690.530.490.460.38
Operating Income0.100.250.280.300.25
Other Income/Expense
Interest Income0.000.000.000.000.00
Interest Expense0.01-0.02-0.010.01-0.01
Other Income/Expense0.000.000.000.020.00
Income
Income Before Tax0.100.190.340.300.15
Income Tax Expense0.030.020.050.040.01
Net Income0.070.170.290.270.14
Net Income - Continuous Operations0.070.170.290.260.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA0.220.310.340.410.30
EBIT0.270.250.280.310.25
Depreciation & Amortization0.110.070.060.030.05
Earnings Per Share
Basic EPS-1.002.002.001.00
Diluted EPS-1.002.002.001.00
Basic Shares Outstanding0.160.160.160.160.15
Diluted Shares Outstanding0.160.160.160.160.16